RNU7-19P

Across TCGA pan-cancer cohorts, RNU7-19P RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated RNU7-19P data layer.

The strongest signal is observed in testicular germ cell tumors (TGCT), where higher RNU7-19P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU7-19P expression acts as an unfavorable survival marker, although some lineages such as LUSC and STAD show a favorable association.

TGCT, COAD, and LUSC are the cancer types where RNU7-19P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
TGCT	OS	Tertile	III,IV	0.003	1.000	<.001	84	view →
COAD	OS	Tertile	IV	0.045	0.659	<.001	63	view →
LUSC	DFS	Tertile	All	1.000	0.368	.009	42	view →
BLCA	OS	Tertile	IV	0.255	0.606	<.001	36	view →
BRCA	DFS	Tertile	All	0.898	0.953	.002	30	view →
CESC	DFS	Tertile	II,III,IV	0.103	0.512	.009	24	view →
PAAD	OS	Tertile	II,III,IV	0.213	0.556	.014	18	view →
UCS	DFS	Tertile	All	0.161	0.529	.026	18	view →
STAD	OS	Quartile	IV	0.860	0.279	.019	11	view →
ESCA	OS	Quartile	II,III,IV	0.552	1.000	.044	6	view →
UCEC	DFS	Tertile	All	0.324	0.707	.034	6	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

RNU7-19P–TGCT (OS)

Open the TGCT breakdown →